Content
Frontiers of Medicine >> 2021, Volume 15, Issue 2 doi: 10.1007/s11684-020-0795-4
Overcoming resistance to endocrine therapy in hormone receptor-positive human epidermal growth factor receptor 2-negative (HR
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing 100021, China
Abstract
Keywords
endocrine-resistant ; HR+/HER2- advanced breast cancer ; randomized clinical trials ; meta-analysis ; targeted therapy
Content